News
Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...
Ayu Life Sciences, an India-based medical devices and cell therapy company, announced plans to establish a new AED33 million ($9 million) advanced manufacturing facility at Jebel Ali Free Zone (Jafza) ...
Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...
3h
AllAfrica on MSNGhana's First Genetically Modified Crop - Why We Created a New Cowpea Variety, How We Tested It and What We Found [analysis]Cowpea (Vigna unguiculata) is an indigenous and staple crop in sub-Saharan Africa, but it has an enemy: an insect called the legume pod borer (Maruca vitrata). This pest can cause yield losses of more ...
BENGALURU: Union Minister of State for Science and Technology and Earth Sciences Jitendra Singh on Thursday emphasised the ...
The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...
UT researchers have created an alternative to Edman degradation for protein sequencing using bases instead of acid ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...
San Diego biotech Halozyme is suing Merck over an injectable version of its blockbuster cancer drug, alleging that the new formulation will infringe on Halozyme's under-the-skin delivery patents.
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results